- Home
- AUTL vs GLAD Comparison
AUTL vs GLAD Comparison
Compare AUTL & GLAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUTL
- GLAD
- Stock Information
- Founded
- AUTL 2014
- GLAD 2001
- Country
- AUTL United Kingdom
- GLAD United States
- Employees
- AUTL N/A
- GLAD N/A
- Industry
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- GLAD Finance/Investors Services
- Sector
- AUTL Health Care
- GLAD Finance
- Exchange
- AUTL Nasdaq
- GLAD Nasdaq
- Market Cap
- AUTL 590.8M
- GLAD 644.5M
- IPO Year
- AUTL 2018
- GLAD N/A
- Fundamental
- Price
- AUTL $1.95
- GLAD $28.79
- Analyst Decision
- AUTL Strong Buy
- GLAD Hold
- Analyst Count
- AUTL 3
- GLAD 1
- Target Price
- AUTL $10.20
- GLAD $23.00
- AVG Volume (30 Days)
- AUTL 1.2M
- GLAD 112.5K
- Earning Date
- AUTL 03-13-2025
- GLAD 02-11-2025
- Dividend Yield
- AUTL N/A
- GLAD 8.27%
- EPS Growth
- AUTL N/A
- GLAD 60.05
- EPS
- AUTL N/A
- GLAD 4.63
- Revenue
- AUTL $10,091,000.00
- GLAD $95,360,000.00
- Revenue This Year
- AUTL $851.88
- GLAD N/A
- Revenue Next Year
- AUTL $220.57
- GLAD $10.44
- P/E Ratio
- AUTL N/A
- GLAD $6.22
- Revenue Growth
- AUTL 82.71
- GLAD 5.53
- 52 Week Low
- AUTL $1.87
- GLAD $19.20
- 52 Week High
- AUTL $6.63
- GLAD $30.43
- Technical
- Relative Strength Index (RSI)
- AUTL 37.49
- GLAD 47.79
- Support Level
- AUTL $1.92
- GLAD $27.02
- Resistance Level
- AUTL $2.15
- GLAD $29.54
- Average True Range (ATR)
- AUTL 0.12
- GLAD 0.61
- MACD
- AUTL 0.01
- GLAD -0.06
- Stochastic Oscillator
- AUTL 22.22
- GLAD 69.14
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.
About GLAD Gladstone Capital Corporation
Gladstone Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its investment objectives are to, achieve and grow current income by investing in debt securities of established businesses that would provide stable earnings and cash flow to pay expenses, make principal and interest payments on its outstanding indebtedness, and make distributions to stockholders that grow over time; and provide its stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses that can grow over time to permit it to sell its equity investments for capital gains.